Adipose Derived Stem Cell Market by Type (Autologous, Allogeneic), Product (Cell Line. Culture Media), Disease (CVS, CNS, MSK, Obesity, Cancer), End User (Hospitals, Tissue Banks, Academia), Application (Therapeutics, Research) - Global Forecasts to 2019
The global adipose derived stem cell market is estimated to grow at a high rate from 2014 to 2019. A number of factors such as increasing private and public funding to support stem cell based researches, growing awareness related to the role of regenerative medicine in disease treatment, rising regulatory approvals for adipose derived stem cell targeted clinical trials across the world, and increasing industry-academia partnerships for development of advanced stem cell line manufacturing technologies are fuelling the growth of adipose derived stem cell market. However, technical limitations related to preservation and scale-up of stem cell lines, high cost associated with stem cell processing, and ethical issues related to the use of allogeneic stem cell lines are some of the key factors hampering the growth of this market.
Emerging markets including China, India, South Korea, and Brazil have become attractive destinations for companies engaged in the development and manufacturing of adipose derived stem cell products. A number of factors such as growing preference for use of adipose derived stem cells in therapeutics and emerging markets offering low regulatory barriers for conducting clinical studies are offering new growth opportunities for players active in the global adipose derived stem cell market
.
AlloCure, Inc. (U.S.), Antria, Inc. (U.S.), Celgene Corporation (U.S.), Cellleris SA (Spain), Corestem, Inc. (South Korea), Cytori Therapeutics, LLC (U.S.), Intrexon, Inc. (U.S.), Mesoblast Ltd. (Australia), Pluristem Therapeutics, Inc. (Ireland), and Tissue Genesis, Inc. (U.S.) are some of the key players present in global adipose derived stem cell market. Over the past three years, these companies adopted new product development and launches, collaborations, agreements, partnerships, and geographical expansions as their key business strategies to ensure their growth in this market.
Scope of the report
This report categorizes the Adipose Derived Stem Cell Market into the following segments and sub-segments:
Adipose Derived Stem Cell Market, by Cell Type
- Autologous Stem Cells
- Allogeneic Stem Cells
Adipose Derived Stem Cell Market, by Product
- Cell Line
- Culture Media
- Media
- Sera
- Reagents
Adipose Derived Stem Cell Market, by Disease
- Cancer
- Obesity
- Wounds and Injuries
- Musculoskeletal Diseases
- Cardiovascular Diseases
- Central Nervous System Diseases
- Metabolic Diseases
- Gastro-intestinal Diseases
- Others
- Hospitals and Trauma Centers
- Cell banks and Tissue Banks
- Research Laboratories and Academic Institutes
- Others
- Therapeutic Application
- Research Application
- Others
Adipose Derived Stem Cell Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K
- Rest of Europe
- Asia-pacific
- China
- India
- Rest of Asia-Pacific
- Rest of the World (RoW)
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Adipose Derived Stem Cell Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Adipose Derived Stem Cell Market